←Back to Expert Scholars
Translational Medicine / 转化医学Dostarlimab dMMR Rectal, Neoadjuvant IO
Andrea Cercek
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Section Head, Colorectal Cancer
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Andrea Cercek led the landmark trial showing 100% complete clinical response to dostarlimab in dMMR rectal cancer, transforming the neoadjuvant management of MSI-H rectal cancer. Her work established immunotherapy as curative in locally advanced dMMR rectal disease.
Share:
🧪Research Fields 研究领域
dostarlimab neoadjuvant
dMMR rectal cancer
organ preservation
complete clinical response
NICHE-2
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Andrea Cercek 的研究动态
Follow Andrea Cercek's research updates
留下邮箱，当我们发布与 Andrea Cercek（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment